Analyst Update: Open Text Corp, T-Mobile US Inc, and Pfizer Inc.

Analysts adjusted their ratings on Open Text Corporation (USA) (NASDAQ:OTEX), T-Mobile US Inc (NYSE:TMUS), and Pfizer Inc. (NYSE:PFE)

by Alex Eppstein

Published on May 21, 2015 at 12:14 PM

Analysts are weighing in today on software firm Open Text Corporation (USA) (NASDAQ:OTEX), telecom titan T-Mobile US Inc (NYSE:TMUS), and blue chip Pfizer Inc. (NYSE:PFE). Here's a quick roundup of today's brokerage notes on OTEX, TMUS, and PFE.

  • OTEX is fresh off an annual low of $42.29, as the company's strategic update last night -- which included lackluster guidance and a planned 5% workforce reduction -- failed to impress. Brokerage firms panned the presentation, with no fewer than 10 cutting their price targets on Open Text Corporation. At last check, the shares were perched nearly 12% lower at $43.19. Should this technical trajectory persist, additional price-target cuts could come down the pike. OTEX's average 12-month price target is $72.82 -- a 69% premium to current trading levels, and in all-time-high territory.

  • On the flip side, TMUS hit a multi-year high of $36.81 earlier, after the CEO of parent company Deutsche Telekom vowed to consider partners to improve the subsidiary's performance, and also added that it is in a better condition now than two years ago. Subsequently, Bernstein upped its price target on T-Mobile US Inc to $36 from $32 -- still a discount to the stock's current price of $36.36. Put buyers may be wringing their hands amid the equity's 3.3% rally. TMUS sports a 10-day put/call volume ratio of 7.31 across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Not only does this ratio indicate more than seven puts have been bought to open for every call during the last two weeks, it likewise stands in the 93rd percentile of its annual range.

  • PFE is up 0.3% at $34.41, after being named a "top global pick" by Jefferies. The shares have performed well in 2015, cruising atop their 20-week moving average for a 10.5% year-to-date gain. It also appears Pfizer Inc.'s 10- and 20-day moving averages are on the verge of a bullish cross, suggesting potential upside ahead. Options traders at the ISE, CBOE, and PHLX have been betting bullishly on PFE of late. The stock's 10-day call/put volume ratio checks in at 5.25 -- higher than four-fifths of comparable readings from the past 12 months.

A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

The Top Lithium Play of 2020
Click to continue to advertiser's site.
First Week in April Provides More Coronavirus-Related Volatility
A slew of coronavirus-related news sent markets on another weekly roller coaster ride
Netflix Stock Heading into Historically Bullish Quarter
NFLX's 10-day moving average has stepped up as support lately
The Top Lithium Play of 2020
Click to continue to advertiser's site.